These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 18547955
1. A randomised study of the effect of two doses of biosynthetic human growth hormone on final height of children with familial short stature. Elder CJ, Barton JS, Brook CG, Preece MA, Dattani MT, Hindmarsh PC. Horm Res; 2008; 70(2):89-92. PubMed ID: 18547955 [Abstract] [Full Text] [Related]
2. A randomised study of two doses of biosynthetic human growth hormone on final height of pubertal children with growth hormone deficiency. Coelho R, Brook CG, Preece MA, Stanhope RG, Dattani MT, Hindmarsh PC. Horm Res; 2008; 70(2):85-8. PubMed ID: 18547954 [Abstract] [Full Text] [Related]
3. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF. J Pediatr; 2005 Jan; 146(1):45-53. PubMed ID: 15644821 [Abstract] [Full Text] [Related]
4. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone. Rachmiel M, Rota V, Atenafu E, Daneman D, Hamilton J. Horm Res; 2007 Jan; 68(5):236-43. PubMed ID: 17396034 [Abstract] [Full Text] [Related]
5. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study. Moore WV, Dana K, Frane J, Lippe B. Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719 [Abstract] [Full Text] [Related]
6. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature. Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board. Horm Res; 2007 Sep; 68(2):53-62. PubMed ID: 17228181 [Abstract] [Full Text] [Related]
7. Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group. Hintz RL, Attie KM, Baptista J, Roche A. N Engl J Med; 1999 Feb 18; 340(7):502-7. PubMed ID: 10021470 [Abstract] [Full Text] [Related]
8. [Effects of clonidine++ administration in children with familial short stature and retarded body growth]. Dorantes-Alvarez L, Coyote-Estrada N, Parra-Paredes S, García-Morales L, Metlich-Medlich B. Bol Med Hosp Infant Mex; 1992 Jul 18; 49(7):422-6. PubMed ID: 1418649 [Abstract] [Full Text] [Related]
9. Growth and growth hormone treatment in short stature children born small for gestational age. Labarta JI, Ruiz JA, Molina I, De Arriba A, Mayayo E, Longás AF. Pediatr Endocrinol Rev; 2009 Feb 18; 6 Suppl 3():350-7. PubMed ID: 19404234 [Abstract] [Full Text] [Related]
10. The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature. Barton JS, Gardineri HM, Cullen S, Hindmarsh PC, Brook CG, Preece MA. Clin Endocrinol (Oxf); 1995 Jun 18; 42(6):619-26. PubMed ID: 7634503 [Abstract] [Full Text] [Related]
11. Growth hormone treatment for short stature in children born small for gestational age. Jung H, Rosilio M, Blum WF, Drop SL. Adv Ther; 2008 Oct 18; 25(10):951-78. PubMed ID: 18836868 [Abstract] [Full Text] [Related]
12. Target height estimation in children with idiopathic short stature who are referred to the growth clinic. Poyrazoglu S, Darendeliler F, Bas F, Bundak R, Saka N, Darcan S, Wit JM, Gunoz H. Horm Res; 2009 Oct 18; 72(3):178-83. PubMed ID: 19729950 [Abstract] [Full Text] [Related]
13. [Final results of the administration of biosynthetic growth hormone. Preliminary report]. Mendoza-Morfín F, Cárdenas-Tirado H, Montero-González P, Bravo-Ríos LE, Gutiérrez-Avila C, Torres-Tamayo M. Gac Med Mex; 1998 Oct 18; 134(1):1-7. PubMed ID: 9658693 [Abstract] [Full Text] [Related]
14. Parentally-adjusted deficit of height as a prognostic factor of the effectiveness of growth hormone (GH) therapy in children with GH deficiency. Hilczer M, Smyczyńska J, Lewiński A. Neuro Endocrinol Lett; 2006 Oct 18; 27(1-2):149-52. PubMed ID: 16648787 [Abstract] [Full Text] [Related]
15. Long-term results of treatment with low-dose fluoxymesterone in constitutional delay of growth and puberty and in genetic short stature. Strickland AL. Pediatrics; 1993 Apr 18; 91(4):716-20. PubMed ID: 8464656 [Abstract] [Full Text] [Related]
16. Near adult heights after growth hormone treatment in patients with idiopathic short stature or idiopathic growth hormone deficiency. Frindik JP, Kemp SF, Hunold JJ. J Pediatr Endocrinol Metab; 2003 May 18; 16 Suppl 3():607-12. PubMed ID: 12795361 [Abstract] [Full Text] [Related]
17. Progressive reduction of relative height in childhood predicts adult stature below target height in boys with constitutional delay of growth and puberty. Wehkalampi K, Vangonen K, Laine T, Dunkel L. Horm Res; 2007 May 18; 68(2):99-104. PubMed ID: 17377395 [Abstract] [Full Text] [Related]
18. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome. Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G. Horm Res; 2009 May 18; 71(3):167-72. PubMed ID: 19188742 [Abstract] [Full Text] [Related]
19. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature. Lampit M, Hochberg Z. J Clin Endocrinol Metab; 2002 Aug 18; 87(8):3573-7. PubMed ID: 12161476 [Abstract] [Full Text] [Related]
20. Acute metabolic effects of human growth hormone on 15N-nitrogen balance in patients with thalassaemia as compared to patients with other types of short stature. Zachmann M, Kempken B, De Sanctis V. J Pediatr Endocrinol Metab; 1998 Aug 18; 11 Suppl 3():851-6. PubMed ID: 10091156 [Abstract] [Full Text] [Related] Page: [Next] [New Search]